Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 11-17 Year-Old Subjects

Clinical trial NCT00464815 · COMPLETED

Trial details

NCT number: NCT00464815
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Infections, Meningococcal

Start date: 2007-05-02
Primary completion: 2008-04-16
Enrollment: 1025

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.